RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. – Edwards Lifesciences Corporation Transaction History
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. portfolio value:
$85.06M
portfolio value
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.26% | 22.75K shares | -10.66M | $82.63 | 1.02M |
| Q2 2022 | share | Increase | +0.39% | 3.92K shares | -22.31M | $95.09 | 1.00M |
| Q1 2022 | share | Increase | +4.63% | 44.40K shares | -6.10M | $117.72 | 1.00M |
| Q4 2021 | share | Increase | +0.75% | 7.10K shares | 16.46M | $130.68 | 958.32K |
| Q3 2021 | share | Increase | +5.21% | 47.10K shares | 14.04M | $113.21 | 951.21K |
| Q2 2021 | share | Increase | +19.80% | 149.43K shares | 30.51M | $103.57 | 904.11K |
| Q1 2021 | share | Increase | +9.02% | 62.44K shares | -31K | $83.64 | 754.68K |
| Q4 2020 | share | Increase | +20.76% | 118.98K shares | 17.39M | $91.23 | 692.23K |
| Q3 2020 | share | Increase | +197.04% | 380.26K shares | 32.42M | $79.82 | 573.25K |
| Q2 2020 | share | Increase | +1.30% | 2.47K shares | 1.35M | $69.11 | 192.98K |
| Q1 2020 | share | Decrease | -23.12% | -57.27K shares | -7.29M | $62.87 | 190.51K |
| Q4 2019 | share | Increase | +29.48% | 56.41K shares | 5.24M | $77.76 | 247.79K |
| Q3 2019 | share | Increase | +6.12% | 11.03K shares | 2.92M | $73.3 | 191.37K |
| Q2 2019 | share | Increase | +44.04% | 55.14K shares | 3.12M | $61.58 | 180.34K |
| Q1 2019 | share | Increase | +19.10% | 20.07K shares | 2.61M | $63.78 | 125.20K |
| Q4 2018 | share | Increase | +8.73% | 8.43K shares | -244K | $51.06 | 105.12K |
| Q3 2018 | share | Increase | +159.03% | 59.36K shares | 3.8M | $58.03 | 96.68K |
| Q2 2018 | share | Increase | +36.50% | 9.98K shares | 539K | $48.52 | 37.32K |
| Q1 2018 | share | Increase | +0.61% | 165 shares | 251K | $46.51 | 27.34K |
| Q4 2017 | share | Decrease | -7.04% | -2.05K shares | -44K | $37.57 | 27.18K |
| Q3 2017 | share | Decrease | -18.72% | -6.73K shares | -353K | $36.44 | 29.23K |
| Q2 2017 | share | Increase | +53.32% | 12.51K shares | 682K | $39.41 | 35.97K |
| Q1 2017 | share | Increase | +9.29% | 1.99K shares | 65K | $31.36 | 23.46K |
| Q4 2016 | share | Decrease | -59.25% | -31.21K shares | -1.44M | $31.23 | 21.46K |
| Q3 2016 | share | Increase | +128.53% | 29.62K shares | 1.35M | $40.19 | 52.68K |
| Q2 2016 | share | Decrease | -12.17% | -3.19K shares | -6K | $33.24 | 23.05K |
| Q1 2016 | share | Increase | 0.00% | 26.24K shares | 772K | $29.4 | 26.24K |